Acute hemodynamic effects of β-blockers in patients with severe congestive heart failure: Comparison of celiprolol and esmolol

Journal of Cardiovascular Pharmacology

Volumn 38, Issue 5, 2001, Pages 666-671

  Felix, Stephan B ^a   Stangl, Verena ^b   Kieback, Arne ^b   Doerffel, Wolf ^b   Staudt, Alexander ^b   Wernecke, Klaus D ^b   Baumann, Gert ^b   Stangl, Karl ^b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Blocker therapy; Celiprolol; Esmolol; Severe heart failure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CELIPROLOL; ESMOLOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; HEART DILATATION; HEMODYNAMICS; HUMAN; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; THERMODILUTION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; CELIPROLOL; DOSE-RESPONSE RELATIONSHIP, DRUG; HALF-LIFE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROPANOLAMINES;

EID: 0034779720     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200111000-00003     Document Type: Article

References (17)

1. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy
2. Effect of carvedilol on morbidity and mortality in patients with chronic heart failure
3. The cardiac insufficiency bisoprolol study II (CIBIS-II): A randomised trial
4. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)
5. The role of β-blockers in left ventricular dysfunction and heart failure
6. β-Adrenergic receptor blockade in chronic heart failure
7. Celiprolol and the heart
8. Clinical safety and efficacy of celiprolol
9. Clinical perspective on celiprolol: Cardio-protective potential
10. Differential actions of atenolol and celiprolol on cardiac performance in ischemic heart disease
11. The central and peripheral hemodynamics of celiprolol
12. Celiprolol, a β-adrenoceptor antagonist with vasodilator effect, improves hemodynamic response to catecholamine, spontaneous locomotor activity, and survival in cardiomyopathic hamsters with advanced heart failure
13. Acute haemodynamic profile of celiprolol in patients with coronary artery disease and hypertension: A double-blind comparison with metoprolol
14. Clinical rationale for the use of an ultra-short acting β-blocker: Esmolol
15. Use of carvedilol in chronic heart failure: Challenges in therapeutic management
16. Hemodynamic effects of celiprolol in patients with ischemic and non-ischemic cardiomyopathy
17. Why do patients with congestive heart failure tolerate the initiation of β-blocker therapy?